Nalmefene for alcohol dependence

Drug and Therapeutics Bulletin

Volumn 52, Issue 5, 2014, Pages 54-57

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

NALMEFENE; PLACEBO; NALTREXONE; NARCOTIC ANTAGONIST;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; DIZZINESS; DRUG EFFICACY; HEALTH SERVICE; HUMAN; INSOMNIA; MORBIDITY; MORTALITY; NAUSEA; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX RATIO; ANALOGS AND DERIVATIVES; DRINKING BEHAVIOR; DRUG APPROVAL; FEMALE; MALE; PREVENTION AND CONTROL; SEX DIFFERENCE; UNITED KINGDOM;

ALCOHOL DRINKING; ALCOHOLISM; DRUG APPROVAL; FEMALE; GREAT BRITAIN; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PREVALENCE; SEX FACTORS;

EID: 84901228111     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2014.5.0252     Document Type: Article

References (29)

1. World Health Organization, 2011. Global status report on alcohol and health, 2011 [online]. Available: http://www.who.int/substance_abuse/publications/ global_alcohol_report/en/ [Accessed 23 April 2014].
2. Department of Health, 2013. Improving outcomes and supporting transparency. Part 1: a public health outcomes framework for England, 2013-2016 [online]. Available: https://www.gov.uk/government/uploads/system/uploads/ attachment_data/file/263658/2901502_PHOF_Improving_Outcomes_PT1A_v1_1. pdf [Accessed 23 April 2014].
3. NHS Health Scotland, 2014. Alcohol [online]. Available: http://www. healthscotland.com/topics/health/alcohol/index.aspx [Accessed 23 April 2014].
4. Health in Wales, 2014. Alcohol [online]. Available: http://www.wales.nhs.uk/ healthtopics/lifestyles/alcohol [Accessed 23 April 2014].
5. Health Social Services and Public Safety. Alcohol and drug misuse [online]. Available: http://www.dhsspsni.gov.uk/alcohol_and_drug_misuse [Accessed 23 April 2014].
6. Selincro 18mg film-coated tablets. Summary of product characteristics, EU. H. Lundbeck A/S, August 2013.
7. PharmaTimes, 2013. UK launch for Lundbeck's alcohol dependency drug Selincro [online]. Available: http://www.pharmatimes.com/article/13-05-09/UK_launch_ for_Lundbeck_s_alcohol_dependency_drug_Selincro.aspx [Accessed 23 April 2014].
8. World Health Organization, 2010. International Classification of Diseases (ICD) [online]. Available: http://www.who.int/classifications/icd/en/ [Accessed 23 April 2014].
9. National Institute for Health and Care Excellence, 2011. CG115: Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence [online]. Available: http://publications.nice.org.uk/ alcohol-use-disorders-diagnosis-assessment-and-management-of-harmfuldrinking-and-alcohol-cg115 [Accessed 23 April 2014].
10. Joint Formulary Committee. British National Formulary. Edition 67. London: BMJ Group and Pharmaceutical Press, March 2014.
11. NHS Choices, 2013. What are the health risks of drinking too much alcohol? [online]. Available: www.nhs.uk/chq/Pages/846.aspx?CategoryID=87&SubCateg oryID=871 [Accessed 23 April 2014].
12. Mann K et al. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry 2012; 73: 706-13.
13. European Medicines Agency, 2010. Guideline on the development of medicinal products for the treatment of alcohol dependence. EMA/CHMP/EWP/20097/2008 [online]. Available: http://www.ema.europa.eu/docs/en_GB/document_library/ Scientific_guideline/2010/03/WC500074898.pdf [Accessed 23 April 2014].
14. World Health Organization, 2000. International guide for monitoring alcohol consumption and related harm [online]. Available: http://whqlibdoc.who.int/ hq/2000/who_msd_msb_00.4.pdf [Accessed 23 April 2014].
15. NHS Choices, 2013. Alcohol units [online]. Available: http://www.nhs.uk/ Livewell/alcohol/Pages/alcohol-units.aspx [Accessed 23 April 2014].
16. Gual A et al. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol 2013; 23: 1432-42.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (text revision). Fourth Edition (DSM-IV-TR). Washington DC: American Psychiatric Association, 2000.
18. Starosta AN et al. The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. J Psychiatr Pract 2006; 12: 80-9.
19. van den Brink W et al. Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomised controlled 6-month studies. Alcohol Alcohol [Epub ahead of print] 19 July 2013; DOI:10.1093/alcalc/agt061.
20. European Medicines Agency, 2012. Assessment report. Selincro [online]. Available: http://www.ema.europa.eu/docs/en_GB/document_library/ EPAR_-_Public_assessment_report/human/002583/WC500140326.pdf [Accessed 23 April 2014].
21. Rehm J et al. Epidemiology and alcohol policy in Europe. Addiction 2011; 106 (S1): 11-19.
22. NHS Business Services Authority, 2014. The electronic drug tariff [online]. Available: http://www.ppa.org.uk/ppa/edt_intro.htm [Accessed 23 April 2014].
23. Scottish Medicines Consortium, 2013. Nalmefene 18mg film-coated tablets (Selincro®) SMC No. (917/13) [online]. Available: http://www. scottishmedicines.org.uk/files/advice/nalmefene_Selincro_FINAL_ September_2013_website.pdf [Accessed 23 April 2014].
24. All Wales Medicines Strategy Group, 2014. Clinical expert summary nalmefene (Selincro®) 18mg film-coated tablets [online]. Available: http://www.awmsg.org/awmsgonline/app/appraisalinfo/1259 [Accessed 23 April 2014].
25. National Institute for Health and Care Excellence, 2011. CG115 Alcohol dependence and harmful alcohol use: costing template [online]. Available: http://guidance.nice.org.uk/CG115/CostingTemplate/xls/ English [Accessed 23 April 2014].
26. London New Drugs Group, 2013. Nalmefene for alcohol dependence [online]. Available: http://www.medicinesresources.nhs.uk/upload/ Nalmefene_final.pdf [Accessed 23 April 2014].
27. National Institute for Health and Care Excellence, 2014. Alcohol dependence-nalmefene [ID660] [online]. Available: http://guidance. nice.org.uk/TAG/442 [Accessed 23 April 2014].
28. National Institute for Health and Care Excellence, 2013. ESNM29 Alcohol dependence: nalmefene [online]. Available: http://www.nice.org.uk/ mpc/evidencesummariesnewmedicines/ESNM29.jsp [Accessed 23 April 2014].
29. All Wales Medicines Strategy Group, 2014. Final Appraisal Recommendation nalmefene (Selincro®) 18 mg film-coated tablets [online]. Available: http://www.awmsg.org/awmsgonline/app/ appraisalinfo/1259 [Accessed 23 April 2014].